Business
Mayne Pharma reports $92 million loss – InDaily
Adelaide-based pharmaceutical company Mayne Pharma has reported a $92.8 million loss for the 2020 financial year, driven by asset write downs in its generic medicines business.
Advertisement
Advertisement
Today’s top stories
PS Canally helping Morgan steam ahead with tourist attraction
Adelaide Uni loses another senior leader
MPs refuse to release documents to ICAC’s entitlements probe
Your views: on COVID-19 marshalls, Centrelink, prison and planning
Rebuilding the Crows: the unthinkable becomes the strategy
Mayne Pharma reports $92 million loss
Adelaide-based pharmaceutical company Mayne Pharma has reported a $92.8 million loss for the 2020 financia…
-
Business18 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
General23 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands
-
Noosa News20 hours agoQueenslanders to continue legal challenges against COVID-19 directives after successful appeal
-
Noosa News13 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track